{ "description": "ValueSet containing drug identifiers to exclude. Criteria is explicitly stating topical, gel, cream, ointment, otic, or ophthalmic formulations.", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "concept": [ { "code": "603978", "display": "nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac]" }, { "code": "1365866", "display": "nepafenac 3 MG/ML Ophthalmic Suspension [Ilevro]" }, { "code": "603977", "display": "nepafenac Ophthalmic Suspension [Nevanac]" }, { "code": "1365864", "display": "nepafenac Ophthalmic Suspension [Ilevro]" }, { "code": "578044", "display": "nepafenac 1 MG/ML Ophthalmic Suspension" }, { "code": "1362132", "display": "nepafenac 3 MG/ML Ophthalmic Suspension" }, { "code": "578043", "display": "nepafenac Ophthalmic Suspension" }, { "code": "1158407", "display": "nepafenac Ophthalmic Product" }, { "code": "1365865", "display": "Ilevro Ophthalmic Product" }, { "code": "1182860", "display": "Nevanac Ophthalmic Product" } ] } ] }, "_filename": "ValueSet-valueset-nepafenac-exclude.json", "package_name": "hl7.fhir.uv.pddi", "date": "2018-07-02", "publisher": "HL7 Clinical Decision Support Workgroup", "jurisdiction": [ { "coding": [ { "code": "001", "system": "http://unstats.un.org/unsd/methods/m49/m49.htm" } ] } ], "purpose": "To refine valueset for Warfarin + NSAID PDDI-CDS", "name": "Valueset_nepafenac_exclude", "copyright": "(copyright expectations unknown)", "type": null, "experimental": "true", "resourceType": "ValueSet", "title": "Exclude Nepafenac Medications Value Set", "package_version": "1.0.0-ballot", "status": "draft", "id": "05b383d2-c28f-4074-88a2-2e187323369b", "kind": null, "url": "http://hl7.org/fhir/uv/pddi/ValueSet/valueset-nepafenac-exclude", "version": "1.0.0-ballot", "contact": [ { "telecom": [ { "value": "http://hl7.org/Special/committees/dss", "system": "url" } ] } ] }